A review of cognitive remediation approaches for schizophrenia: from top-down to bottom-up, brain training to psychotherapy

Expert Review of Neurotherapeutics
Michael W Best, Christopher R Bowie

Abstract

Individuals with psychotic disorders experience profound impairment in neurocognition, which is consistently found to be the best predictor of independent community functioning. Several diverse behavioural treatments designed to enhance neurocognitive abilities have been developed, with subtle to stark differences among them. Various approaches, to varying degrees, have demonstrated success across diffuse outcomes: improved brain structure and function, performance on neuropsychological tests, and community activities associated with daily living. Areas covered: This paper reviews the different approaches to cognitive remediation and the differential effects these approaches have on neurophysiological function, neurocognitive abilities, and real-world community functioning. Cognitive remediation approaches can be broadly classified along two dimensions: 1) treatment target, and 2) treatment modality. Some approaches target more basic perceptual skills, some target higher level executive processes, while some are non-targeted and seek to improve general cognitive ability. With regard to modality, approaches might have little/no therapist involvement and rely exclusively on computerized practice or they may include intensive ther...Continue Reading

Associated Clinical Trials

References

Jan 1, 1991·European Archives of Psychiatry and Clinical Neuroscience·M Hermanutz, J Gestrich
Jan 1, 1990·European Archives of Psychiatry and Neurological Sciences·R Olbrich, L Mussgay
May 1, 1989·The British Journal of Clinical Psychology·R H Benedict, A E Harris
Jan 1, 1974·Acta Psychiatrica Scandinavica·D H Ingvar, G Franzén
Jan 1, 1994·Schizophrenia Bulletin·R H BenedictR F Asarnow
Aug 1, 1993·Psychological Medicine·J R CrawfordM Bremner
Jan 1, 1993·Schizophrenia Bulletin·D L Braff
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Apr 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·D I VelliganC V Flores
Dec 1, 1996·The Australian and New Zealand Journal of Psychiatry·A Delahunty, R Morice
Jan 1, 1995·Journal of the International Neuropsychological Society : JINS·J S PaulsenD V Jeste
Mar 21, 1998·Schizophrenia Bulletin·A MedaliaA E Merriam
Jul 23, 1998·Neuropsychology·R W Heinrichs, K K Zakzanis
Apr 21, 1999·Brain Research. Brain Research Reviews·W Klimesch
Oct 12, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·A Russo-NeustadtC W Cotman
May 10, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·G WintererR Coppola
Oct 24, 2000·Schizophrenia Research·S R McGurk, H Y Meltzer
Dec 6, 2000·Psychiatry Research·A MedaliaS Watras-Gans
Mar 20, 2001·Archives of General Psychiatry·D M BarchJ D Cohen
May 10, 2001·Schizophrenia Research·M E ShentonR W McCarley
May 17, 2001·Schizophrenia Bulletin·A MedaliaM Casey
Jun 6, 2002·Schizophrenia Bulletin·Mark van der GaagRobert P Liberman
Jun 8, 2002·Annual Review of Neuroscience·David A Lewis, Pat Levitt
Sep 12, 2002·Schizophrenia Research·Alice MedaliaMatthew Casey
Jul 16, 2003·Psychiatry Research·Beatriz López-Luengo, Carmelo Vázquez
Aug 27, 2004·Schizophrenia Research·Elvira BramonSophia Frangou
Sep 1, 2004·Journal of Psychiatric Practice·Alice Medalia, Rosa Lim
Sep 8, 2004·Archives of General Psychiatry·Gerard E HogartyRebecca Zoretich
Feb 9, 2005·Archives of General Psychiatry·Gregory A Light, David L Braff
May 6, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Jimmy Choi, Alice Medalia
May 12, 2005·Schizophrenia Research·Gudrun SartoryKlaus Windgassen
May 13, 2005·Schizophrenia Bulletin·Roland VauthRainer Vater
Dec 6, 2005·Biological Psychiatry·Todd LenczBarbara A Cornblatt
Apr 28, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Richard S E KeefeJeffrey A Lieberman
Jun 23, 2006·Neuroreport·Yuki KawakuboNobumasa Kato

❮ Previous
Next ❯

Citations

Jan 19, 2018·Journal of the American Geriatrics Society·Eric J Lenze, Christopher R Bowie
Feb 12, 2019·Expert Review of Neurotherapeutics·Clément DondéFrédéric Haesebaert
May 7, 2019·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Michael F GreenJunghee Lee
Jan 28, 2020·Journal of the International Neuropsychological Society : JINS·B C CastelluccioJ K Johannesen
May 1, 2020·Psychological Medicine·Matteo CellaAntonio Preti
Apr 26, 2020·CNS Spectrums·Benjamin RoseStephen M Stahl
May 16, 2020·International Journal of Environmental Research and Public Health·Gabriele NibbioAntonio Vita
Mar 29, 2020·Early Intervention in Psychiatry·Takahiro NemotoMasafumi Mizuno
Dec 13, 2019·Schizophrenia Research. Cognition·Benedetta SeccomandiMatteo Cella
Apr 23, 2021·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Ramiro ReckziegelClarissa S Gama
Dec 13, 2019·Schizophrenia Research. Cognition·Michael W BestChristopher R Bowie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.